
Treatment With Tolvaptan In ADPKD Patients : Results From An Observational , Multicentric Study
In recent years, treatment of ADPKD (Autosomal Dominant Polycystic Kidney of the Adult) has been based on the antisecretive and

In recent years, treatment of ADPKD (Autosomal Dominant Polycystic Kidney of the Adult) has been based on the antisecretive and

The vascular endothelium has been described as the largest organ of the body. The luminal surface of all vascular endothelial

Blood pressure (BP) and volume status have emerged as key factors influencing outcomes in maintenance dialysis patients, affecting patients’ symptoms,

The huge array of gut micro-organisms that together comprise the human microbiome is now recognized as a truly metabolic organ

Maintenance dialysis is lifesaving, but patients have significantly higher rates of cardiovascular mortality and cognitive impairment due to circulatory stress

Dialysis therapy of patients at increased risk of bleeding is a well-known clinical problem. Systemic anticoagulation with heparin increases the

Finerenone is a novel, selective, nonsteroidal mineralocorticoid receptor antagonist (MRA) that significantly reduced the risk of adverse kidney and cardiovascular

Inflammation is a main mechanism for the pathogenesis and progression of diabetic kidney disease (DKD). Interleukin-6 (IL-6) is an important

Chronic kidney disease (CKD) and atrial fibrillation (AF) are both risk factors for bleeding, stroke and mortality. Whether the combination

People with type 2 diabetes mellitus (T2DM) have a greater risk of cardiovascular (CV) disease and major adverse CV events